Homo sapiens Gene: PPP2CB
Summary
InnateDB Gene IDBG-15988.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol PPP2CB
Gene Name protein phosphatase 2, catalytic subunit, beta isozyme
Synonyms PP2Abeta; PP2CB;
Species Homo sapiens
Ensembl Gene ENSG00000104695
Encoded Proteins
protein phosphatase 2, catalytic subunit, beta isozyme
protein phosphatase 2, catalytic subunit, beta isozyme
protein phosphatase 2, catalytic subunit, beta isozyme
protein phosphatase 2, catalytic subunit, beta isozyme
protein phosphatase 2, catalytic subunit, beta isozyme
protein phosphatase 2, catalytic subunit, beta isozyme
Protein Structure
Useful resources Stemformatics EHFPI ImmGen
Entrez Gene
Summary This gene encodes the phosphatase 2A catalytic subunit. Protein phosphatase 2A is one of the four major Ser/Thr phosphatases, and it is implicated in the negative control of cell growth and division. It consists of a common heteromeric core enzyme, which is composed of a catalytic subunit and a constant regulatory subunit, that associates with a variety of regulatory subunits. This gene encodes a beta isoform of the catalytic subunit. [provided by RefSeq, Mar 2010]
Gene Information
Type Protein coding
Genomic Location Chromosome 8:30774457-30814314
Strand Reverse strand
Band p12
Transcripts
ENST00000221138 ENSP00000221138
ENST00000523023 ENSP00000429927
ENST00000518564 ENSP00000428142
ENST00000518532
ENST00000522113
ENST00000520334 ENSP00000430758
ENST00000523804
ENST00000518243 ENSP00000428618
ENST00000520056 ENSP00000428866
ENST00000520500
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 123 experimentally validated interaction(s) in this database.
They are also associated with 6 interaction(s) predicted by orthology.
Experimentally validated
Total 123 [view]
Protein-Protein 123 [view]
Protein-DNA 0
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Predicted by orthology
Total 6 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0004721 phosphoprotein phosphatase activity
GO:0004722 protein serine/threonine phosphatase activity
GO:0005515 protein binding
GO:0008022 protein C-terminus binding
GO:0016787 hydrolase activity
GO:0046872 metal ion binding
Biological Process
GO:0006470 protein dephosphorylation
GO:0008152 metabolic process
GO:0008543 fibroblast growth factor receptor signaling pathway
GO:0008637 apoptotic mitochondrial changes
GO:0010468 regulation of gene expression
GO:0016311 dephosphorylation
GO:0034976 response to endoplasmic reticulum stress
GO:0042542 response to hydrogen peroxide
GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process
GO:0046580 negative regulation of Ras protein signal transduction
GO:0046677 response to antibiotic
Cellular Component
GO:0000159 protein phosphatase type 2A complex
GO:0000775 chromosome, centromeric region
GO:0000922 spindle pole
GO:0005634 nucleus
GO:0005737 cytoplasm
GO:0005829 cytosol
GO:0070062 extracellular vesicular exosome
Orthologs
Species
Mus musculus
Bos taurus
Gene ID
Gene Order
Method
Confidence
Comments
Non-SSD Ortholog
Possible paralog/unusual divergence/ gene prediction error
Not yet available
Non-SSD Ortholog
Possible paralog/unusual divergence/ gene prediction error
Pathways
NETPATH
REACTOME
Cyclin A/B1 associated events during G2/M transition pathway
Signaling by FGFR in disease pathway
Integration of energy metabolism pathway
truncated APC mutants destabilize the destruction complex pathway
G1 Phase pathway
MyD88 dependent cascade initiated on endosome pathway
Beta-catenin phosphorylation cascade pathway
Signalling by NGF pathway
AXIN mutants destabilize the destruction complex, activating WNT signaling pathway
Toll Like Receptor 7/8 (TLR7/8) Cascade pathway
APC truncation mutants are not K63 polyubiquitinated pathway
AMER1 mutants destabilize the destruction complex pathway
Toll Like Receptor TLR1:TLR2 Cascade pathway
misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling pathway
Toll Like Receptor 9 (TLR9) Cascade pathway
Signaling by WNT in cancer pathway
Toll Like Receptor TLR6:TLR2 Cascade pathway
Myoclonic epilepsy of Lafora pathway
AXIN missense mutants destabilize the destruction complex pathway
Signaling by Wnt pathway
MyD88 cascade initiated on plasma membrane pathway
Mitotic G1-G1/S phases pathway
Metabolism of carbohydrates pathway
Signaling by GPCR pathway
Innate Immune System pathway
ERKs are inactivated pathway
disassembly of the destruction complex and recruitment of AXIN to the membrane pathway
Toll Like Receptor 3 (TLR3) Cascade pathway
APC truncation mutants have impaired AXIN binding pathway
Toll Like Receptor 2 (TLR2) Cascade pathway
Cyclin D associated events in G1 pathway
Toll-Like Receptors Cascades pathway
Spry regulation of FGF signaling pathway
Degradation of beta-catenin by the destruction complex pathway
Opioid Signalling pathway
T41 mutants of beta-catenin aren't phosphorylated pathway
G1/S Transition pathway
Signal Transduction pathway
Separation of Sister Chromatids pathway
MAP kinase activation in TLR cascade pathway
misspliced GSK3beta mutants stabilize beta-catenin pathway
S45 mutants of beta-catenin aren't phosphorylated pathway
deletions in the AMER1 gene destabilize the destruction complex pathway
Mitotic Prometaphase pathway
Cell Cycle pathway
Adaptive Immune System pathway
Inhibition of replication initiation of damaged DNA by RB1/E2F1 pathway
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation pathway
Immune System pathway
MyD88-independent cascade pathway
MyD88:Mal cascade initiated on plasma membrane pathway
Platelet homeostasis pathway
S33 mutants of beta-catenin aren't phosphorylated pathway
truncations of AMER1 destabilize the destruction complex pathway
M Phase pathway
Mitotic Anaphase pathway
phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex pathway
PP2A-mediated dephosphorylation of key metabolic factors pathway
TCF dependent signaling in response to WNT pathway
E2F mediated regulation of DNA replication pathway
NGF signalling via TRKA from the plasma membrane pathway
G2/M Transition pathway
Mitotic Prophase pathway
Glycolysis pathway
MASTL Facilitates Mitotic Progression pathway
deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling pathway
Cell Cycle, Mitotic pathway
RNF mutants show enhanced WNT signaling and proliferation pathway
TCF7L2 mutants don't bind CTBP pathway
Toll Like Receptor 4 (TLR4) Cascade pathway
Activated TLR4 signalling pathway
Nuclear Events (kinase and transcription factor activation) pathway
Signaling by FGFR pathway
Mitotic G2-G2/M phases pathway
Metabolism pathway
Negative regulation of FGFR signaling pathway
MAPK targets/ Nuclear events mediated by MAP kinases pathway
XAV939 inhibits tankyrase, stabilizing AXIN pathway
DARPP-32 events pathway
TRIF-mediated TLR3/TLR4 signaling pathway
Costimulation by the CD28 family pathway
Platelet sensitization by LDL pathway
CTLA4 inhibitory signaling pathway
Resolution of Sister Chromatid Cohesion pathway
ERK/MAPK targets pathway
Toll Like Receptor 5 (TLR5) Cascade pathway
S37 mutants of beta-catenin aren't phosphorylated pathway
Disease pathway
Toll Like Receptor 10 (TLR10) Cascade pathway
Glucose metabolism pathway
Glycogen storage diseases pathway
Hemostasis pathway
Mitotic Metaphase and Anaphase pathway
KEGG
mRNA surveillance pathway pathway
Oocyte meiosis pathway
TGF-beta signaling pathway pathway
Tight junction pathway
Long-term depression pathway
Chagas disease (American trypanosomiasis) pathway
Hepatitis C pathway
INOH
PID BIOCARTA
PID NCI
TGF-beta receptor signaling
Cross-References
SwissProt
TrEMBL H0YC23
UniProt Splice Variant
Entrez Gene 5516
UniGene Hs.491440
RefSeq NM_001009552
HUGO HGNC:9300
OMIM 176916
CCDS CCDS6079
HPRD 01487
IMGT
EMBL AC009314
GenPept
RNA Seq Atlas 5516